Lords Mark Industries Unlisted Shares
Lords Mark Industries Ltd — Acquires Renalyx to Expand AI-Driven Dialysis Technology
MSN
2 min read
Expert Analysis:
Lords Mark Industries Ltd has acquired a majority stake (85%) in Bengaluru-based Renalyx Health Systems, strengthening its presence in the medical technology and renal care segment. The acquired company will continue to operate as an independent unit while supporting Lords Mark’s broader healthcare strategy.
Renalyx is the developer of India’s first AI-powered and IoT-enabled smart haemodialysis machine (RxT-21), which enables features such as remote monitoring, real-time clinical data access, and integration with telenephrology platforms to enhance dialysis treatment and patient safety.
The dialysis technology is expected to be manufactured in collaboration with Bharat Electronics, with Lords Mark having received a manufacturing licence in September 2025, positioning the company to scale indigenous MedTech innovation under the “Make in India” initiative.
Key Takeaway:
Lords Mark Industries’ acquisition of Renalyx marks a strategic expansion into advanced renal care technology, leveraging AI-enabled dialysis solutions and domestic manufacturing capabilities to strengthen its footprint in India’s growing MedTech ecosystem.
Precize Daily Pulse
The latest news in the world of Unlisted Shares, summarised by our experts.
Company
Our Office
Office No. 1219, The Summit Business Park, Andheri Kurla Road, Andheri East, Mumbai, Maharashtra - 400093
Find us on Googlesupport@precize.in
+91 7738336457
All trademarks and logos or registered trademarks and logos found on this Site or mentioned herein belong to their respective owners and are solely used for informational and educational purposes.
The material presented in this advertisement is for informational purposes only and should not be construed as investment advice or investment availability. It is not a recommendation of, or an offer to sell or solicitation of an offer to buy, any particular unlisted share, security, strategy, or investment product. Investing in the private market and securities involves risks, including the potential loss of money, and past performance does not guarantee future results. Market trends, data interpretations, graph projections are provided for informational and illustrative purposes and may not reflect actual future performance. Nothing on this website should be construed as personalized investment advice or should not be treated as legal, financial, or any other form of advice. Precize is not liable for financial or any other form of loss incurred by the user or any affiliated party based on information provided herein.
Precize is neither a stock exchange nor does it intend to get recognized as a stock exchange under the Securities Contracts Regulation Act, 1956. Precize is not authorized by the capital markets regulator to solicit investments. The securities traded on these platforms are not traded on any regulated exchange.
The website will be updated regularly.
Copyright © 2026 - Precize - All Rights Reserved